Pulmonx Corporation provided earnings guidance for the full year 2024. For the period, the company expects revenue for the full year 2023 to be in the range of $81 million to $84 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.71 USD | +3.57% | -5.82% | -31.45% |
05-01 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
05-01 | Transcript : Pulmonx Corporation, Q1 2024 Earnings Call, May 01, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.45% | 326M | |
+73.48% | 12.41B | |
-18.22% | 8.23B | |
+2.68% | 6.46B | |
+15.76% | 5.5B | |
-4.95% | 5.33B | |
+40.80% | 5.1B | |
-18.32% | 4.05B | |
-28.53% | 2.54B | |
+7.56% | 1.99B |
- Stock Market
- Equities
- LUNG Stock
- News Pulmonx Corporation
- Pulmonx Corporation Provides Earnings Guidance for the Full Year 2024